CSIMarket
 


Alaunos Therapeutics Inc   (TCRT)
Other Ticker:  
 
 

TCRT's Operating Income Growth by Quarter and Year

Alaunos Therapeutics Inc 's Operating Income results by quarter and year




TCRT Operating Income (in millions $) FY 2023 FY 2022 FY 2021 FY 2020
IV Quarter December - -8.52 -11.05 -20.32
III Quarter September -8.66 -8.26 -22.30 -18.61
II Quarter June -7.98 -9.23 -22.64 -18.66
I Quarter March -9.67 -9.09 -21.56 -16.04
FY   -26.31 -35.10 -77.55 -73.63



TCRT Operating Income third quarter 2023 Y/Y Growth Comment
Alaunos Therapeutics Inc in the third quarter 2023 recorded Operating Loss of $ -8.66 millions.

According to the results reported in the third quarter 2023, Alaunos Therapeutics Inc achieved the best Operating Income growth in Major Pharmaceutical Preparations industry. While Alaunos Therapeutics Inc ' s Operating Income no change of % ranks overall at the positon no. in the third quarter 2023.

Explain Operating Income growth


TCRT Operating Income ( Y/Y Growth %) 2023
2022 2021 2020
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Alaunos Therapeutics Inc 's third quarter 2023 Operating Income $ -8.66 millions TCRT's Income Statement
Alaunos Therapeutics Inc 's third quarter 2022 Operating Income $ -8.26 millions Quarterly TCRT's Income Statement
New: More TCRT's historic Operating Income Growth >>


TCRT Operating Income (Quarter on Quarter Growth %)

2023
2022 2021 2020
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




Operating Income third quarter 2023 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Operating Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Operating Income third quarter 2023 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Operating Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Operating Income by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

Alaunos Therapeutics Inc 's Q/Q Operating Income Growth


Operating Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


TCRT's III. Quarter Q/Q Operating Income Comment
Recent results of -8.66 millions by Alaunos Therapeutics Inc appear even more unfavourable if you take a look at -7.98 millions Operating Loss in the second quarter.

Within Major Pharmaceutical Preparations industry Alaunos Therapeutics Inc achieved highest sequential Operating Income growth. While Alaunos Therapeutics Inc 's Operating Income growth quarter on quarter, overall rank is .


Operating Income Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Operating Income Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Operating Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


TCRT's III. Quarter Q/Q Operating Income Comment
Current Operating Loss of -8.66 millions by Alaunos Therapeutics Inc come out even more unfavourable compare to the -7.98 millions in the previous quarter.

Within Major Pharmaceutical Preparations industry Alaunos Therapeutics Inc achieved highest sequential Operating Income growth. While Alaunos Therapeutics Inc 's Operating Income growth quarter on quarter, overall rank is .


Alaunos Therapeutics Inc 's 12 Months Operating Income Growth Year on Year


Operating Income TTM Growth

12 Months Ending
(Sep 30 2023)
12 Months Ending
(Jun 30 2023)
12 Months Ending
(Mar 31 2023)
12 Months Ending
(Dec 31 2022)
12 Months Ending
(Sep 30 2022)
Cumulative Operating Income 12 Months Ending $ -34.84 $ -34.44 $ -35.69 $ -35.11 $ -37.63
Y / Y Operating Income Growth (TTM) - - - - -
Year on Year Operating Income Growth Overall Ranking # # # # #
Seqeuential Operating Income Change (TTM) - - - - -
Seq. Operating Income Growth (TTM) Overall Ranking # # # # #




Cumulative Operating Income growth Comment


Alaunos Therapeutics Inc achieved highest trailing twelve month year on year Operating Income growth. While overall Operating Income growth ranking, remained unchanged compare to the previous quarter at no. .

Operating Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Operating Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Operating Income growth Comment


Alaunos Therapeutics Inc achieved highest trailing twelve month year on year Operating Income growth. While overall Operating Income growth ranking, remained unchanged compare to the previous quarter at no. .

Operating Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Operating Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Operating Income Growth
Major Pharmaceutical Preparations Industry Operating Income Growth Trends and Statistics
Healthcare Sector Operating Income Growth Statistics
Operating Income Growth Trends for overall market
TCRT's Operating Income Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Operating Income Growth
Lowest Ranking Operating Income Growth
Operating Income Growth for TCRT's Competitors
Operating Income Growth for Alaunos Therapeutics Inc 's Suppliers
Operating Income Growth for TCRT's Customers

You may also want to know
TCRT's Annual Growth Rates TCRT's Profitability Ratios TCRT's Asset Turnover Ratio TCRT's Dividend Growth
TCRT's Roe TCRT's Valuation Ratios TCRT's Financial Strength Ratios TCRT's Dividend Payout Ratio
TCRT's Roa TCRT's Inventory Turnover Ratio TCRT's Growth Rates TCRT's Dividend Comparisons



Companies with similar Operating Income no change for the quarter ending Sep 30 2023 within Healthcare SectorY/Y Change %Operating Income for the quarter ending Sep 30 2023
Amedisys Inc 8.43%$ 8.425 millions
Hca Healthcare Inc 7.79%$ 7.787 millions
Chemed Corporation7.41%$ 7.412 millions
Ensign Group Inc7.41%$ 7.410 millions
Dariohealth Corp 6.68%$ 6.677 millions
U S Physical Therapy Inc6.62%$ 6.620 millions
Halozyme Therapeutics Inc 5.99%$ 5.987 millions
Gamida Cell Ltd 5.73%$ 5.727 millions
Resmed Inc 4.81%$ 4.808 millions
Prestige Consumer Healthcare Inc 4.58%$ 4.581 millions
United Therapeutics Corporation4.04%$ 4.041 millions
Edwards Lifesciences Corporation3.98%$ 3.976 millions
Universal Health Services Inc 3.44%$ 3.435 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com